Naronapride
- Generic Name
- Naronapride
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C27H41ClN4O5
- CAS Number
- 860174-12-5
- Unique Ingredient Identifier
- 058896B00B
- Indication
Investigated for use/treatment in gastroesophageal reflux disease (GERD) and gastroparesis.
- Associated Conditions
- -
- Associated Therapies
- -
Different Doses of Naronapride vs. Placebo in Gastroparesis
- First Posted Date
- 2022-11-18
- Last Posted Date
- 2024-08-15
- Lead Sponsor
- Dr. Falk Pharma GmbH
- Target Recruit Count
- 320
- Registration Number
- NCT05621811
- Locations
- 🇺🇸
Dr Falk Investigational Site, Harlingen, Texas, United States
🇧🇪University of Leuven, Leuven, Belgium
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath